psychedelics
Treating addiction and depression with a non-hallucinogenic version of the psychedelic drug ibogaine
Preliminary study suggests that “microdoses” of psychedelics may enhance a person’s creative problem solving abilities
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a ‘reset’
Scientific evidence of a ‘higher’ state of consciousness has been found in a study led
Psilocybin study at Johns Hopkins shows considerable relief for cancer-related anxiety or depression
In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people
When people take the psychedelic drug LSD, they sometimes feel as though the boundary that
Drugs researcher David Nutt discusses brain-imaging studies with hallucinogens. Researchers have published the first images
A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases
PSYCHEDELIC drugs like LSD and magic mushrooms should be made legal as banning them is
It’s time to let scientists study whether LSD, marijuana and ecstasy can ease psychiatric disorders